You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

ipilimumab

( IP-i-LIM-ue-mab )
Funding:
New Drug Funding Program
  • Ipilimumab - Previously Untreated Advanced Unresectable Melanoma
  • Ipilimumab - Previously Treated Advanced Unresectable Melanoma
  • Nivolumab plus Ipilimumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)
  • Nivolumab plus Ipilimumab – Metastatic Renal Cell Carcinoma
Other Name(s): Yervoy®
Appearance: clear, colourless to pale yellow solution which may be mixed into a larger bag of fluid

You might also be interested in